CORT

#1303
Corcept Therapeutics Inc.
35.7000
+3.13%
Sector:
Base:
Profit Currency:
Daily Range
35.7000
35.7000
Year Range
28.6601
89.0000
Daily Change
+3.13%
Monthly Change
-22.83%
6 month change
-51.34%
Year Change
-51.34%
Previous Close
34.6150
Open
35.7000
Bid
Ask
Low
35.7000
High
35.7000
Volume
111
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

News